PCT Filing Fee Reductions in January 2015

December 14, 2014

wipo_pct_logo270savings

The official fees incurred for filing, prosecuting, registering and renewing patents, designs and trademarks in Israel are linked to the cost of living index. Twice a year, on 1 January and on 1 June, they are adjusted. It seems that living in Israel is ever more expensive, and each adjustment makes each fee a few Shekels more.

WIPO works differently. From time to time their fees for PCT related services are adjusted, but not necessarily upwards.

As of 1 January 2015 the basic international filing fee for a PCT application will drip from $1471 to $1384. Excess page fees will drop from $17 a page to $16 a page.

If one elects the EPO as the international Search and Examination Office, the search will cost $2366 instead of the current $2545.

Using PCT Easy saves $104 per application, and filing electronically as XML or similar saves $208. It is possible to combine these and file electronically using PCT Easy, saving $312.

 

 

 

 


European and Israel Patent Offices Sign a Bilateral PPH

December 10, 2014

pph

The European Patent Office (EPO) and the Israel Patent Office (IPO) have agreed a patent deal set to speed up examinations at both offices. Starting next month, the Patent Prosecution Highway (PPH) will allow applicants to request accelerated examination of a patent at either office provided the claims have been previously deemed acceptable by the other. The agreement was signed on December 4 by heads of both offices in Brussels, Belgium.

Apparently Asa Kling, director of the IPO, said the programme would “enhance co-operation between the offices” and further strengthen the economic and technological relations between Israel and Europe.

COMMENT
We see this as a great development, not least because Israel Applications may be accelerated fairly easily under a variety of routes including Section 17c of the Israel Patent Law 1967 and relevant patent office circulars. European Applications can linger in the queue for examination for quite a while, and incur annual maintenance fees. Then again, once allowed, a European patent has to be ratified and is then subject to renewal fees in the countries where it is ratified. The main thing is that this gives applicants choice and flexibility.


IL 153925 to Samsung to Be Published for Reinstatement

December 10, 2014

face

IL 153925 titled “SYSTEM AND METHOD FOR AUTOMATICALLY DETECTING NEUTRAL EXPRESSIONLESS FACES IN DIGITAL IMAGES” was first filed by IBM, was assigned to a company called IPO Healthcare based in Guernsey. It was transferred to a US law company called Bollinger Lane LLC in March 2010, and then on to Samsung Electronics later that year. In its peregrinations, the fact that the patent needed periodic renewal went amiss. It wasn’t docketed properly with Samsung’s renewal service.

Based on an affidavit from Samsung, it was determined that the patent going abandoned was unintentional, and the patent office has published a revival request for opposition purposes.

 

 

 


Orbotech Challenges Cost Ruling, but too Late

December 8, 2014

missed opportunity

Back on 9th November 2014, I reported that after finally ruling on the Camtek – Orbotech patent Opposition, the Israel Patent Office ruled very large costs to Adi Levit, mostly because he’d detailed his cost calculation and it was unchallenged by Orbotech who’d lost the case.

Camtek requested 302,895 Shekels costs (including VAT).  The request for costs were supported by an affidavit from Camtek’s IP manager Michael Lev. The sum includes legal fees of 288,687 Shekels to outside counsel, Adi Levit, 8208 Shekels to the witness Mr Golan, and 6000 Shekels for intermediate costs awarded. All cost requests were supported by documentary evidence such as invoices from outside counsel and salary slips from the witness. Orbotech, represented by Reuven Borchowski, did not counter the request for costs.

In her ruling, Ms Jacqueline Bracha reviewed the intermediate costs to see whether they were affected by the final decision and came to the conclusion that where she had ruled that the costs were incurred by Opposer unnecessarily, they should be discounted.  The costs awarded were 296,895 Shekels.

Apparently, on the day that the cost ruling issued, Orbotech requested that the ruling be canceled, arguing that because of industrial action in the courts, they were unable to respond on the last day as they had intended.

Camtek responded that they could have filed a notice of intent to challenge, the court strike was actually the day after, and a response could have been submitted despite the strike. They requested that Orbotech’s lawyer file an affidavit testifying to why he was unable to respond, and to be prepared to be cross-examined on it.

Ms Bracha decided that the ruling was given fairly and there was no reason to cancel it. The issue was not whether Reuven Borchovsky, attorney for Orbotech had intended filing a response, but whether there were counter-arguments on file when she made her ruling. As there weren’t, she was entitled to simply check the calculation submitted by Adv. Levit. Consequently, she saw no reason to cancel her decision to award the actual legal costs + witness fee – intermediate costs that were unnecessary.


The Mattress Opposition Again

December 3, 2014

wisdom of solomon

Moshe and Anat Gabai have developed a mattress that they believe is useful in minimizing the occurrence of Sudden Infant Death Syndrome (SIDS) in children. On allowance, Aminach, a large Israel mattress manufacturer opposed the patent issuing.

The Applicants who were not represented, managed to overcome the prior art objections relating to novelty and non-obviousness, but were unable to prove that their mattress was effective. Consequently, Deputy Commissioner Ms Jacqueline Bracha ruled that the patent be cancelled as contravening Section 3 due to it lacking utility.

At the time, the Applicants did not have experimental evidence, but they teamed up with a scientist and generated some evidence that their mattress had some value in minimizing cot deaths.

The Applicants appealed to the District Court, however the District Court was not willing to examine this new evidence that wasn’t before the Patent Office.

Undeterred, and this time with professional assistance, the applicants appealed to the Supreme Court which established that in such circumstances, new evidence may be submitted. The case was referred back to the District Court which ruled that the evidence could be accepted and referred the case back to the Israel Patent Office.

Ms Bracha is prepared to accept the evidence provided it is relevant.

COMMENT

I can develop a persuasive theory that the mattress design allows dissipation of carbon dioxide and helps a baby that is lying face down to breath freely. I can think of several ways of demonstrating utility and have discovered a university researcher who is able to run some useful experiments. Unfortunately, the only really convincing evidence would be to conduct experiments with a statistically significant pool of identical twin babies, one twin sleeping on regular mattresses and the other on the Applicant’s mattress. I find the idea a little obnoxious and do not see that utility requires proof.

I think the Gabai’s deserve a patent for this, and am impressed with their tenaciousness.


Ethics for Israel Patent Attorneys

November 23, 2014

ethical and legal

In what some may consider a welcome move, the Ministry of Justice has published a first draft version of a law that will govern the behavior of Israel Patent Attorneys.  For the draft, see here.

Perhaps the most significant thing about the draft law is that client-attorney privilege is formally recognized. Henceforth, Patent Attorneys will also be required to keep escrow accounts.

The IP Committee of the Israel Bar considers that the standards required of Patent Attorneys should be equivalent to those required of Attorneys-At-Law, and considers that the current state of affairs allows Patent Attorneys more freedom regarding marketing. They have requested that this be addressed. The attorney signed on their proposed response is Ziv Glasner who is also a patent attorney.

The Association of Patent Attorneys in Israel has submitted their comments to the Justice Ministry as an amended draft. Briefly, the Association of Patent Attorneys in Israel would like the code of ethics of patent attorneys to mirror that of the Israel Bar Law (Professional Ethics) 1988 mutatis mutandis, seeing a correlation between the two professions.  Thus the draft law as proposed by the Ministry of Justice recognizes that a patent attorney who is also an attorney-at-law will be duty-bound by both the Code of Ethics that bind patent attorneys and by the Israel Bar Law (Professional Ethics) 1988, however in case of conflict, the behaviour required of Attorneys-at-Law will prevail. In contradistinction, the Association does not see room for conflict between requirements of an Attorney-at-Law and those of a Patent Attorney as it wants the Code of Ethics for Patent Attorneys to mirror that for Attorneys at Law.

If we were talking about ethics, where the standards required of Patent Attorneys and Attorneys at law differ, one would require the attorney to have the highest standards. However, this proposed Law is not about ethics, it is about behaviour.

The proposed law legislates and formalizes much of the voluntary code adhered to by the Association of Israel Patent Attorneys that Dr Kfir Luzzatto drafted some years ago. However, the amendment proposed by the Association of Israel Patent Attorneys wishes to delete certain sections such as not denigrating competitors and not aggressively poaching clients, as these are not currently binding on Attorneys-at-Law. Instead, the Association’s propose to import a whole bunch of clauses from the Israel Bar Law (professional ethics) relating to where Attorneys can set up office and where they can meet clients and make these binding on Patent Attorneys as well.

I am concerned that these restrictions will create an entry barrier against sole practitioners and new firms, and should not be allowed on constitutional grounds based on the Basic Law, Freedom of Occupation 1992. Clearly restrictions designed to protect the public are legitimate. However, I do not think that Read the rest of this entry »


Another Israel Patent Lapses Despite Timely Payment of Fees

November 11, 2014

Online payment

Israel patent number 213651 relates to a method of saving water. The patent issued on 31 August 2013, and the deadline for paying the renewal fee was 30 November 2013. Due to failure to pay the fee in a timely manner, once the grace period passed, it was considered as having lapsed from November 2013 and a notice that the patent had lapsed was subsequently published in the Israel Patent Office Journal of July 2014.

In October 2014 the patentee filed a request for reinstatement. The agent of record argued that the patentee had paid the renewal fee in a timely manner, however proof of payment was not sent to the Israel Patent Office. On discovering the error in June 2014, the agent of record contacted the patent office to discover what had happened, believing that proof of payment had been submitted. On discovering that proof of payment had not been received at the patent office, he took steps to revive the patent.

From the chain of events, the Deputy Commissioner, Ms Jacqueline Bracha, was assured that the patentee had not intended the patent to lapse and the fact that the patent had been paid but only the proof of payment had not been submitted was considered further evidence that the patentee had intended to renew the patent. There was a lack of explanation as to why so much time had passed from when the fact that the patent had lapsed was known to the patentee to when a reinstatement request was filed. Nevertheless, noting that the Israel Patent Office was closed for festivals, Ms Bracha allowed the request for reinstatement, and  this has published for opposition purposes.


Follow

Get every new post delivered to your Inbox.

Join 300 other followers